Search results for "Prognosis."

showing 10 items of 2044 documents

Coincident vesical transitional cell carcinoma and prostatic carcinoma. Clinical features and treatment.

1986

Summary— Twenty-two patients with vesical urothelial carcinoma associated with prostatic carcinoma were reviewed. They represented 1.5% of the bladder and prostatic tumours treated in our department within a 12-year period from 1968 to 1979. Their management included several treatment policies, based on the separate assessment of each tumour variant. For non-infiltrating bladder tumours, transurethral tumour resection was combined with hormonal treatment, external radiotherapy or resection of the prostate depending on the stage of the prostatic tumour. Radical cystoprostatectomy was performed for two cases of infiltrating bladder tumour with well localised prostatic tumours. A conservative …

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentTumor resectionUrologyCystoprostatectomyNeoplasms Multiple PrimaryProstatemedicineCarcinomaHumansNeoplasm InvasivenessStage (cooking)PathologicalAgedCarcinoma Transitional Cellbusiness.industryCancerProstatic NeoplasmsMiddle Agedmedicine.diseasePrognosismedicine.anatomical_structureTransitional cell carcinomaUrinary Bladder NeoplasmsbusinessBritish journal of urology
researchProduct

Primary Radical Prostatectomy or Ablative Radiotherapy as Protective Factors for Patients With mCRPC Treated With Radium-223 Dichloride: An Italian M…

2020

Abstract Background We investigated, in a real-life setting, the prognostic relevance of previous primary treatment (radical prostatectomy [RP] or external beam radiotherapy [EBRT]) on overall survival for patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 (223Ra). Materials and Methods In the present multicenter retrospective study, we enrolled 275 consecutive patients. The demographic and clinical data and mCRPC characteristics were recorded and evaluated at baseline and at the end of treatment or progression. 223Ra was administered according to the current label authorization until disease progression or unacceptable toxicity. We divided the who…

Malemedicine.medical_specialtyUrologymedicine.medical_treatmentoverall survivalBrachytherapy030232 urology & nephrologyUrology223-ra03 medical and health sciencesProstate cancer0302 clinical medicineAblative casemedicineHumansExternal beam radiotherapyradiotherapyAgedRetrospective StudiesAged 80 and overProstatectomyRadioisotopesbusiness.industryProstatectomyRetrospective cohort studymCRPCMiddle AgedProtective Factorsmedicine.diseasePrognosisCombined Modality TherapyRadiation therapySurvival RateProstatic Neoplasms Castration-ResistantOncologyMulticenter study223-ra; mCRPC; prostatectomy; radiotherapy; overall survivalItaly030220 oncology & carcinogenesisCohortDisease ProgressionbusinessSettore SECS-S/01Follow-Up StudiesRadium
researchProduct

Pulmonary embolism: risk assessment and management.

2012

Acute pulmonary embolism (PE) poses a significant burden on health and survival. Its severity ranges from asymptomatic, incidentally discovered subsegmental thrombi to massive, pressor-dependent PE complicated by cardiogenic shock and multisystem organ failure. Rapid and accurate risk stratification is therefore of paramount importance to ensure the highest quality of care. This article critically reviews currently available and emerging tools for risk-stratifying acute PE, and particularly for distinguishing between elevated (intermediate) and low risk among normotensive patients. We focus on the potential value of risk assessment strategies for optimizing severity-adjusted management. Apa…

Malemedicine.medical_specialtyVena Cava FiltersVitamin Kmedicine.medical_treatmentEarly TherapyRisk AssessmentSeverity of Illness IndexRecurrenceSeverity of illnessmedicineAmbulatory CareHumansThrombolytic TherapyIntensive care medicineAgedRandomized Controlled Trials as TopicThrombectomybusiness.industryHeparinCardiogenic shockAnticoagulantsThrombolysisLength of StayMiddle Agedmedicine.diseasePrognosisPulmonary embolismCardiac Imaging TechniquesEmbolismAcute DiseaseFemaleCardiology and Cardiovascular MedicineMultiple organ dysfunction syndromeRisk assessmentbusinessPulmonary EmbolismBiomarkersEuropean heart journal
researchProduct

D-Dimer and thrombus burden in acute pulmonary embolism.

2018

Abstract Background Thrombus burden in pulmonary embolism (PE) is associated with higher D-Dimer-levels and poorer prognosis. We aimed to investigate i) the influence of right ventricular dysfunction (RVD), deep venous thrombosis (DVT), and high-risk PE-status on D-Dimer-levels and ii) effectiveness of D-Dimer to predict RVD in normotensive PE patients. Methods Overall, 161 PE patients were analyzed retrospectively, classified in 5 subgroups of thrombus burden according to clinical indications and compared regarding D-Dimer-levels. Linear regression models were computed to investigate the association between D-Dimer and the groups. In hemodynamically stable PE patients, a ROC curve was calc…

Malemedicine.medical_specialtyVentricular Dysfunction Right030204 cardiovascular system & hematologyLogistic regressionFibrin Fibrinogen Degradation Products03 medical and health sciences0302 clinical medicineInternal medicineD-dimerLinear regressionmedicineHumans030212 general & internal medicineAgedRetrospective StudiesVenous Thrombosisbusiness.industryCancerGeneral Medicinemedicine.diseasePrognosisPulmonary embolismVenous thrombosisPneumoniaROC CurveThrombus burdenAcute DiseaseEmergency MedicineCardiologyFemalebusinessPulmonary EmbolismBiomarkersThe American journal of emergency medicine
researchProduct

Right ventricular dysfunction in hemodynamically stable patients with acute pulmonary embolism

2013

Abstract Background Echocardiography for risk stratification in hemodynamically stable patients with pulmonary embolism (PE) is well-established. Right ventricular dysfunction (RVD) is associated with an elevated mortality and adverse outcome. The aim of our study was to compare RVD criteria and investigate the role of elevated systolic pulmonary artery pressure (sPAP) in the diagnosis of RVD. Methods We retrospectively analyzed the echocardiographic and laboratory data of all hemodynamically stable patients with confirmed PE (2006-2011). The data were compared with three different definitions of RVD: Definition 1: RV dilatation, abnormal motion of interventricular septum, RV hypokinesis or…

Malemedicine.medical_specialtyVentricular Dysfunction RightInternal medicinemedicine.arteryTroponin ImedicineHumansInterventricular septumAgedRetrospective StudiesAged 80 and overmedicine.diagnostic_testbiologyVentilation/perfusion scanbusiness.industryTroponin IHeartHematologyMiddle AgedRight bundle branch blockPrognosismedicine.diseaseTroponinPulmonary embolismmedicine.anatomical_structureEchocardiographyAcute DiseasePulmonary arterybiology.proteinCardiologyFemalePulmonary EmbolismbusinessElectrocardiographyThrombosis Research
researchProduct

Multicenter prospective study on the use and outcome of rehabilitation after total laryngectomy in Germany

2018

Background The purpose of this study was to assess the use and outcome of rehabilitation after total laryngectomy in Germany. Methods We enrolled patients who were scheduled for total laryngectomy, approached them again after surgery, after 3 months and 1 year. Patients completed questionnaires and were interviewed. Results Of 309 participants, 14% had not received any rehabilitation. Reasons for nonuse were primarily ongoing treatment and poor health. Users of rehabilitation had 4 times the odds of attaining any ability to speak compared to nonusers (odds ratio 3.8, P = .02). The main aim of rehabilitation from the perspective of the users was speech rehabilitation, mentioned by 71% before…

Malemedicine.medical_specialtyVoice Qualitymedicine.medical_treatmentLaryngectomySpeech TherapyOutcome (game theory)OddsCohort Studies03 medical and health sciences0302 clinical medicineQuality of lifeReference ValuesGermanySurveys and QuestionnairesmedicineHumansProspective Studies030223 otorhinolaryngologyProspective cohort studyLaryngeal NeoplasmsPostoperative CareRehabilitationbusiness.industrySpeech IntelligibilityOdds ratioSpeech rehabilitationPrognosisLaryngectomyTreatment OutcomeOtorhinolaryngologyPatient Satisfaction030220 oncology & carcinogenesisQuality of LifePhysical therapyFemaleLarynx ArtificialbusinessHead & Neck
researchProduct

Long-term outcomes after acute myocardial infarction in patients with familial hypercholesterolemia: The French registry of Acute ST-elevation and no…

2020

Patients with familial hypercholesterolemia (FH) are prone to develop acute myocardial infarction (AMI) at a younger age.The aim of the present study was to assess 5-year outcomes after AMI according to the presence of FH in a large multicenter cohort of patients.The French registry of Acute ST-elevation and non-ST-elevation Myocardial Infarction consists of nationwide surveys recruiting patients over a 1- to 2-month period every 5 years. Patients recruited in 2005 and 2010 were followed up to 5 years.Of 5147 patients discharged alive and in whom FH status could be assessed, 2.8% had probable/definite FH, using an adapted Dutch Lipid Clinic score. They were 12 years younger, on average, tha…

Malemedicine.medical_specialty[SDV]Life Sciences [q-bio]Endocrinology Diabetes and MetabolismFamilial hypercholesterolemia030204 cardiovascular system & hematologyCohort StudiesHyperlipoproteinemia Type II03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineSurveys and QuestionnairesInternal MedicinemedicineHumansIn patient030212 general & internal medicineMyocardial infarctionRegistriesNon-ST Elevated Myocardial InfarctionStrokeComputingMilieux_MISCELLANEOUSAgedNutrition and Dieteticsbusiness.industryST elevationHazard ratioMiddle Agedmedicine.diseasePrognosisConfidence interval3. Good healthCohortST Elevation Myocardial Infarction[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieFemaleFranceHydroxymethylglutaryl-CoA Reductase InhibitorsCardiology and Cardiovascular MedicinebusinessJournal of clinical lipidology
researchProduct

Neuronal Correlates of Clinical Asymmetry in Progressive Supranuclear Palsy

2014

Progressive supranuclear palsy (PSP) is characterized by a symmetric hypokinetic syndrome with early falls and vertical supranuclear gaze palsy. However, clinically asymmetric manifestations occur, resembling idiopathic Parkinson disease or corticobasal degeneration. The aim of this study was to determine the neuronal correlates of patients suffering from PSP with a lateralized disease manifestation (hemi-PSP) in comparison to patients with symmetric clinical presentation (symPSP) and corticobasal degeneration.Twenty-three patients with PSP and 8 patients with corticobasal degeneration according to standard diagnostic criteria underwent F-fluorodeoxyglucose (FDG) PET scans to assess disease…

Malemedicine.medical_specialtybehavioral disciplines and activitiesBrain mappingProgressive supranuclear palsyPhysical medicine and rehabilitationFluorodeoxyglucose F18mental disordersHumansMedicineCorticobasal degenerationRadiology Nuclear Medicine and imagingAgedAged 80 and overNeuronsBrain MappingVertical supranuclear gaze palsybusiness.industryGeneral MedicinePrognosismedicine.diseaseeye diseasesnervous system diseasesSupranuclear palsyPositron-Emission TomographyFemaleSupranuclear Palsy ProgressivebusinessClinical Nuclear Medicine
researchProduct

Exercise cardiac power and the risk of heart failure in men: A population-based follow-up study.

2019

Little is known about exercise cardiac power (ECP), defined as the ratio of directly measured maximal oxygen uptake with peak systolic blood pressure during exercise, on heart failure (HF) risk. We examined the association of ECP and the risk of HF.This was a population-based cohort study of 2351 men from eastern Finland. The average time to follow-up was 25 years. Participants participated at baseline in an exercise stress test. A total of 313 cases of HF occurred.Men with low ECP (9.84 mL/mmHg, the lowest quartile) had a 2.37-fold (95% confidence interval (95%CI): 1.68-3.35, p0.0001) hazards ratio of HF as compared with men with high ECP (13.92 mL/mmHg, the highest quartile), after adjust…

Malemedicine.medical_specialtyeducationPopulationPhysical Therapy Sports Therapy and RehabilitationPopulation basedCohort Studies03 medical and health sciencesfluids and secretions0302 clinical medicineInternal medicineMedicineHumansOrthopedics and Sports Medicine030212 general & internal medicineeducationExerciseHeart Failureeducation.field_of_studybusiness.industryFollow up studiesVO2 max030229 sport sciencesmedicine.diseasePrognosisBlood pressureQuartileHeart failureCardiologybusinessCohort studyFollow-Up StudiesJournal of sport and health science
researchProduct

Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure?

2007

To assess whether circulating levels of carbohydrate antigen 125 (CA125) predict subsequent 6-month all-cause mortality in patients after the index hospitalisation for acute heart failure (HF).Prospective cohort study at a single teaching centre in Spain.529 consecutive patients with acute HF admitted in a single university centre were analysed. In addition to the traditional clinical information, CA125 (U/ml) was measured during the early course of hospitalisation. The independent association between baseline CA125 and mortality was assessed with Cox regression analysis. The follow-up was limited to 6 months.349 (66%) patients showed serum levels of CA12535 U/ml (established cut-off point …

Malemedicine.medical_specialtyendocrine system diseasesCardiac Output LowKaplan-Meier EstimateCohort StudiesRisk FactorsInternal medicineEpidemiologymedicineHumansRisk factorProspective cohort studyAgedProportional Hazards ModelsHeart FailureProportional hazards modelbusiness.industryCase-control studyMiddle AgedPrognosismedicine.diseasefemale genital diseases and pregnancy complicationsSurgeryHospitalizationHeart Failure and CardiomyopathyQuartileCA-125 AntigenCase-Control StudiesHeart failureAcute DiseaseFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersCohort studyHeart
researchProduct